(Q33692392)

English

Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a pha

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a pha (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

adaptive radiation therapy

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

object named as

Zhen Chen

7

1 reference

ORCID Public Data File 2021

author name string

Jian-Dong Zhao

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jin Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Zhi-Gang Ren

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ke Gu

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Zhen-Hua Zhou

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Wen-Tao Li

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Zhi-Yong Xu

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Lu-Ming Liu

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Guo-Liang Jiang

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

12 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Radiation Oncology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

Radiation therapy for hepatocellular carcinoma: from palliation to cure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

Global cancer statistics, 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

The Ras-Raf-MEK-ERK pathway in the treatment of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

BAY 43-9006: preclinical data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

21 June 2018

Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

30 October 2018

Sample size considerations for non-randomized comparative studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829587

30 October 2018

Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20149262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20149262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20149262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20149262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge

1 reference

https://pubmed.ncbi.nlm.nih.gov/20149262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20149262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of active breathing control in 3-dimensional conformal radiation therapy for hepatocellular carcinoma: the feasibility and benefit

1 reference

https://pubmed.ncbi.nlm.nih.gov/20149262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1748-717X-5-12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33692392&oldid=2195654052"